Found: 5
Select item for more details and to access through your institution.
Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in mice.
- Published in:
- International Journal of Cancer, 2008, v. 122, n. 1, p. 57, doi. 10.1002/ijc.23013
- By:
- Publication type:
- Article
Modulation of urokinase-type plasminogen activator and metalloproteinase activities in cultured mouse mammary-carcinoma cells: Enhancement by paclitaxel and inhibition by nocodazole.
- Published in:
- International Journal of Cancer, 1999, v. 83, n. 2, p. 242, doi. 10.1002/(SICI)1097-0215(19991008)83:2<242::AID-IJC16>3.0.CO;2-8
- By:
- Publication type:
- Article
CIGB-300 anticancer peptide regulates the protein kinase CK2-dependent phosphoproteome.
- Published in:
- Molecular & Cellular Biochemistry, 2020, v. 470, n. 1/2, p. 63, doi. 10.1007/s11010-020-03747-1
- By:
- Publication type:
- Article
TELOMERASA Y TELÓMERO: SU ESTRUCTURA Y DINÁMICA EN SALUD Y ENFERMEDAD.
- Published in:
- Medicina (Buenos Aires), 2014, v. 74, n. 1, p. 69
- By:
- Publication type:
- Article
The synthetic peptide CIGB-300 modulates CK2-dependent signaling pathways affecting the survival and chemoresistance of non-small cell lung cancer cell lines.
- Published in:
- Cancer Cell International, 2017, v. 17, p. 1, doi. 10.1186/s12935-017-0413-y
- By:
- Publication type:
- Article